Benitec Biopharma (ASX:BLT)


The Sydney-based Benitec Biopharma (ASX: BLT), established in 1995, is a clinical-stage biotechnology company which develops novel genetic medicines in laboratories in Hayward, California (USA), with collaborators and licensees around the world. It has a patent over DNA-directed RNA interference or ddRNAi platform, which combines RNA interference, or RNAi, and gene therapy to develop medicines that assist in silencing of disease-causing genes following a single administration for a sustained period of time.

Similar Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK